Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: HER2 receptor | Statement: [CLEOPATRA trial, biologicTarget, HER2 receptor]

Target entity: HER2 receptor
Context triple: [CLEOPATRA trial, biologicTarget, HER2 receptor]

• A. HER2 receptor chosen
  The HER2 receptor is a cell surface protein and member of the epidermal growth factor receptor family that, when overexpressed, drives the growth of certain aggressive breast and other cancers.
• B. ERBB2
  ERBB2, also known as HER2, is a receptor tyrosine kinase frequently overexpressed in certain breast and other cancers and serves as a key therapeutic target.
• C. EGFR
  EGFR (epidermal growth factor receptor) is a transmembrane receptor tyrosine kinase that regulates cell growth and survival and is frequently implicated in cancer development and progression.
• D. epidermal growth factor receptor family
  The epidermal growth factor receptor family is a group of closely related receptor tyrosine kinases (including EGFR/HER1, HER2, HER3, and HER4) that regulate cell growth, survival, and differentiation and are key targets in cancer biology and therapy.
• E. ERBB4
  ERBB4 is a receptor tyrosine kinase of the ErbB/EGFR family involved in cell signaling pathways that regulate cell growth, differentiation, and development.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target predicate: biologicTarget
Context triple: [CLEOPATRA trial, biologicTarget, HER2 receptor]

• A. regulatoryTarget
  Indicates that one entity is subject to control, influence, or governance by another entity under a regulatory or rule-based framework.
• B. hasMolecularTarget chosen
  Indicates that one entity (such as a drug or compound) is directed toward, binds to, or specifically interacts with a particular molecular target (such as a protein, receptor, or gene).
• C. hasTargetDisease
  Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
• D. targetsGene
  Indicates that one entity is directed toward, acts upon, or is intended to affect a specific gene.
• E. targetOrganism
  Indicates that an action, process, or effect is directed toward or intended to impact a particular organism.
• F. None of above.